Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-17 @ 1:43 PM
Ignite Modification Date:
2025-12-22 @ 12:56 PM
NCT ID:
NCT00262561
Eligibility Criteria:
Inclusion Criteria:
* Atherosclerosis of the lower limbs, defined by one of the following criteria: Ankle-Brachial Pressure Index (ABPI)\< 0.9, intermittent claudication, ischaemic pain at rest, ischaemic ulcers or gangrene.
* Age \> 18 years
* For fertile women: Use of safe contraception (intrauterine contraceptive device, the pill, hormonal skin patches, progestogen injections, progestogen implant, vaginal ring)
Exclusion Criteria:
* Allergy to either Aspirin or Clopidogrel
* Known bleeding disorder
* Platelet count \< 140 mia/L or \> 400 mia/L
* Intake of NSAID's, SSRI's or Dipyridamol within the preceding 14 days
* Not radically treated gastrointestinal ulceration within the last 6 month
* Greater surgical procedures performed within the last 3 month
* Severe renal disease
* Severe hepatic disease
* Breast feeding
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00262561
Study Brief:
Protocol Section:
NCT00262561